More than 150 techies packed the house at a Claude Code meetup event in Seattle on Thursday evening, eager to trade use cases ...

Leadgene Biosolutions today announces the expansion of its product portfolio following its strategic integration into Leadgene Biomedical. The expanded portfolio supports both early-stage cell line ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced that it has been honored with the Research and ...

Dealerware, a leading software platform servicing automotive OEMs and retailers, today announced it has been acquired by a group of growth investors led by Wavecrest Growth Partners and Radian Capital ...

Pricing of $12.5 Million Registered Direct Offering & Concurrent Private Placement Offerings priced at-the-market under ...

Detailed price information for Ivanhoe Mines Ltd (IVN-T) from The Globe and Mail including charting and trades.

The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...

Google plans to shift the early development of its premium Pixel smartphones to Vietnam this year, marking a major change in ...

Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, ...

Early-stage regulatory strategy is becoming a powerful driver of speed, risk reduction, and commercial value in drug ...

Over the last two years, more than 350 SKUs have been added across multiple categories at the Atit, India, site ...

Definium’s late-stage pipeline includes four Phase 3 trials—two each for GAD and MDD—anchored by its lead candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD.